Jan Sinclair

622 total citations
21 papers, 280 citations indexed

About

Jan Sinclair is a scholar working on Immunology, Surgery and Immunology and Allergy. According to data from OpenAlex, Jan Sinclair has authored 21 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Surgery and 6 papers in Immunology and Allergy. Recurrent topics in Jan Sinclair's work include Food Allergy and Anaphylaxis Research (6 papers), Immunodeficiency and Autoimmune Disorders (6 papers) and Eosinophilic Esophagitis (5 papers). Jan Sinclair is often cited by papers focused on Food Allergy and Anaphylaxis Research (6 papers), Immunodeficiency and Autoimmune Disorders (6 papers) and Eosinophilic Esophagitis (5 papers). Jan Sinclair collaborates with scholars based in New Zealand, United States and United Kingdom. Jan Sinclair's co-authors include Rohan Ameratunga, Lesley Voss, Diana Lennon, Carlos A. Camargo, Penny Fitzharris, Cameron Grant, Helen Heffernan, Edwin A. Mitchell, Josh Knight and Alistair W. Stewart and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Allergy and Current Pharmaceutical Design.

In The Last Decade

Jan Sinclair

20 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Sinclair New Zealand 10 79 60 54 50 47 21 280
Morteza Fallahpour Iran 12 114 1.4× 126 2.1× 27 0.5× 54 1.1× 180 3.8× 59 440
Gennadiy Drozdenko Germany 8 170 2.2× 47 0.8× 39 0.7× 127 2.5× 75 1.6× 8 401
Jennifer Raab Germany 11 29 0.4× 36 0.6× 89 1.6× 32 0.6× 41 0.9× 18 366
Sophie M. Worobec United States 8 20 0.3× 16 0.3× 63 1.2× 30 0.6× 16 0.3× 23 305
Denisa Ferastraoaru United States 11 129 1.6× 149 2.5× 32 0.6× 14 0.3× 124 2.6× 37 504
Valérie Legrain France 6 20 0.3× 22 0.4× 51 0.9× 31 0.6× 9 0.2× 12 294
Dalia El‐Ghoneimy Egypt 8 95 1.2× 35 0.6× 22 0.4× 5 0.1× 59 1.3× 22 234
Gérard Champion France 8 116 1.5× 13 0.2× 181 3.4× 33 0.7× 14 0.3× 17 538
Silja Domm Germany 8 215 2.7× 12 0.2× 79 1.5× 34 0.7× 30 0.6× 12 346
Rania Jounblat Lebanon 12 75 0.9× 10 0.2× 91 1.7× 19 0.4× 28 0.6× 14 318

Countries citing papers authored by Jan Sinclair

Since Specialization
Citations

This map shows the geographic impact of Jan Sinclair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Sinclair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Sinclair more than expected).

Fields of papers citing papers by Jan Sinclair

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Sinclair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Sinclair. The network helps show where Jan Sinclair may publish in the future.

Co-authorship network of co-authors of Jan Sinclair

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Sinclair. A scholar is included among the top collaborators of Jan Sinclair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Sinclair. Jan Sinclair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Labrosse, Roxane, Sara Barmettler, Beáta Dérfalvi, et al.. (2021). Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients. Journal of Allergy and Clinical Immunology. 148(2). 523–532.e8. 33 indexed citations
2.
Richards, Stephanie, Andrew R. Gennery, E. Graham Davies, et al.. (2020). Diagnosis and management of severe combined immunodeficiency in Australia and New Zealand. Journal of Paediatrics and Child Health. 56(10). 1508–1513. 2 indexed citations
3.
Grant, Cameron, Julian Crane, Edwin A. Mitchell, et al.. (2016). Vitamin D supplementation during pregnancy and infancy reduces aeroallergen sensitization: a randomized controlled trial. Allergy. 71(9). 1325–1334. 59 indexed citations
4.
Ameratunga, Rohan, Richard Steele, A. M. Jordan, et al.. (2016). The case for a national service for primary immune deficiency disorders in New Zealand.. PubMed. 129(1436). 75–90. 7 indexed citations
5.
Preece, Kahn, et al.. (2016). Paediatric non-IgE mediated food allergy: guide for practitioners.. PubMed. 129(1430). 78–88. 3 indexed citations
6.
Sinclair, Jan, Shannon Brothers, Thorsten Stanley, et al.. (2013). IgE-mediated food allergy--diagnosis and management in New Zealand children.. PubMed. 126(1380). 57–67. 1 indexed citations
7.
Sinclair, Jan. (2013). Fatal food allergy and opportunities for risk minimisation.. PubMed. 126(1375). 99–101. 1 indexed citations
8.
Sinclair, Jan, et al.. (2009). Fatty Acids and Obesity. Current Pharmaceutical Design. 15(36). 4117–4125. 10 indexed citations
9.
Ameratunga, Rohan, G. C. Simmons, Clare Wall, et al.. (2008). The changing epidemiology of food allergy--implications for New Zealand.. PubMed. 121(1271). 74–82. 6 indexed citations
10.
Fitzharris, Penny, et al.. (2006). Anaphylaxis management: the essential role of adrenaline (epinephrine) auto-injectors. Should PHARMAC fund them in New Zealand?. PubMed. 119(1233). U1965–U1965. 3 indexed citations
11.
Baumgart, Karl, Simon G.A. Brown, Michael Gold, et al.. (2004). ASCIA guidelines for prevention of food anaphylactic reactions in schools, preschools and child‐care centres. Journal of Paediatrics and Child Health. 40(12). 669–671. 24 indexed citations
12.
Ameratunga, Rohan, et al.. (2004). Increased risk of adverse events when changing intravenous immunoglobulin preparations. Clinical & Experimental Immunology. 136(1). 111–113. 37 indexed citations
13.
Empson, Marianne, Jan Sinclair, J O'donnell, et al.. (2004). The assessment and management of primary antibody deficiency.. PubMed. 117(1195). U914–U914. 12 indexed citations
14.
Sinclair, Jan, et al.. (2003). Advanced age, but not anergy, is associated with altered serum polyunsaturated fatty acid levels.. PubMed. 7(6). 378–84. 5 indexed citations
15.
Sinclair, Jan, et al.. (1999). CHRONIC PARVOVIRUS B19 MENINGITIS IN A CHILD WITH ACUTE LYMPHOCYTIC LEUKEMIA. The Pediatric Infectious Disease Journal. 18(4). 395–396. 12 indexed citations
16.
Sinclair, Jan. (1999). How statistics can be used to promote better health care.. PubMed. 95(25). 44–6. 1 indexed citations
17.
Chin, Simon, et al.. (1998). A child with recurrent infections. Acta Paediatrica. 87(10). 1097–1099. 1 indexed citations
18.
Sinclair, Jan & William T. Shearer. (1997). Current Status of CD4-Based Therapies for Prophylaxis and Treatment of HIV Infection. BioDrugs. 8(2). 128–138. 2 indexed citations
19.
Lennon, Diana, Lesley Voss, Jan Sinclair, & Helen Heffernan. (1989). An outbreak of meningococcal disease in Auckland, New Zealand. The Pediatric Infectious Disease Journal. 8(1). 11–15. 29 indexed citations
20.
Voss, Lesley, Diana Lennon, & Jan Sinclair. (1989). The clinical features of paediatric meningococcal disease Auckland, 1985-87.. PubMed. 102(868). 243–5. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026